Home › Cancer (all types) › Florida
Cancer (all types) clinical trials in Florida
127 studies for Cancer (all types) are looking for participants at sites in Florida.
Cities in Florida
- Tampa38 studies
- Miami36 studies
- Jacksonville29 studies
- Orlando24 studies
- Sarasota10 studies
- Gainesville9 studies
- Plantation7 studies
- Cape Coral7 studies
- Fort Lauderdale6 studies
- Hollywood6 studies
- St. Petersburg6 studies
- Deltona5 studies
- Coral Springs5 studies
- Davie5 studies
- Kendall4 studies
- Hialeah4 studies
- Boca Raton3 studies
- Deerfield Beach3 studies
- Miami Beach3 studies
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Boca Raton Clinical Research Coral Springs, Coral Springs
- Regis Clinical Research LLC, Miami
- Florida Clinical Trials Group Tamarac, Tamarac
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Nov 13, 2026 · NCT05920356Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes
- Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System, Pembroke Pines
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07672769A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
- University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 1003), Miami
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT06818643000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
- Mayo Clinic Flordia, Jacksonville
RecruitingPhase 1/2
Ages 15 to 99 · All sexes · Updated Nov 12, 2026 · NCT05588141A Study of YL242 in Subjects With Advanced Solid Tumors
- US-202, Sarasota
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07197827Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
- University of Miami, Miami
- Moffitt Cancer Center, Tampa
RecruitingObservational study
All ages · All sexes · Updated Nov 12, 2026 · NCT06423950KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
- Clermont Oncology Center ( Site 0041), Clermont
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07252739RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of South Florida, Department of Psychiatry and Behavioral Neuroscience, Tampa
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Nov 10, 2026 · NCT07002034Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Holy Cross Hospital, Fort Lauderdale
- Broward Health Medical Center, Fort Lauderdale
- UF Health Cancer Institute - Gainesville, Gainesville
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT06580314Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Advent Health, Orlando
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07195591A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- Florida Cancer Specalists, Sarasota
- Moffitt Cancer Center, Tampa
RecruitingPhase 1
Ages 18 to 99 · All sexes · Updated Nov 6, 2026 · NCT06983743Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Clermont Oncology Center, Clermont
- Mid Florida Hematology and Oncology Center, Orange City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT04198766A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
- University of Florida, Gainesville
- Mayo Clinic in Florida, Jacksonville
- University of Miami, Miami
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 100 · All sexes · Updated Nov 5, 2026 · NCT05655494REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
- Bioresearch Partner- Hialeah Hospital, Hialeah
- Helios Clinical Research, North Miami Beach
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07410117A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
- Florida Clinical Trials Group, Plantation
RecruitingPhase 1
Ages 18 to 99 · All sexes · Updated Nov 5, 2026 · NCT07540572A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
- BRCR Global - Tamarac, Tamarac
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07169851A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- Moffit Cancer center, Tampa
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06150157A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Millennium Oncology Research Clinic, Hollywood
- Miami Cancer Institute at Baptist Health, Inc., Miami
- Ocala Oncology Center PL DBA Florida Cancer Affiliates - Ocala, Ocala
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06119581A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
- Florida Cancer Specialists & Research Institute - Sarasota Cattlemen, Sarasota
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07578571A Study of JNJ-1761981 in Participants With Solid Tumors
- Mayo Clinic in Florida, Jacksonville
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07525141Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- The Mayo Clinic - Jacksonville, Davis-E, Jacksonville
- Sylvester Comprehensive Cancer Center, University of Miami Hospital and Clinics, Miami
- Baptist Cancer Center, Miami
- and 2 more
RecruitingPhase 2/3
All ages · All sexes · Updated Nov 2, 2026 · NCT03435796A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
- Moffitt Cancer Center, Tampa
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT06010329Visugromab in Cachexia International Trial
- Clermont Oncology Center, Clermont
- Mid Florida Hematology and Oncology Centers, Orange City
- Cleveland Clinic Martin Health, Stuart
- and 1 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07112196A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- Johns Hopkins All Children's Hospital ( Site 4025), St. Petersburg
RecruitingPhase 1/2
1 Month – 17 Years · All sexes · Updated Oct 30, 2026 · NCT07630974Met Non Small Cell Cancer Registry (MOMENT)
- Holy Cross Health, Fort Lauderdale
RecruitingObservational study
All ages · All sexes · Updated Oct 29, 2026 · NCT05376891Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment
- Mayo Clinic in Florida, Jacksonville
Recruiting
Ages 18 to 90 · All sexes · Updated Oct 26, 2026 · NCT07221409Multi-Cancer Detection Observational Cohort Study
- Mayo Clinic in Florida, Jacksonville
RecruitingObservational studyHealthy volunteers welcome
Ages 21 and older · All sexes · Updated Oct 26, 2026 · NCT06962995A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Research Site, Orlando
- Research Site, Tampa
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT06835569Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Mayo Clinic Jacksonville, Jacksonville
- Moffitt Cancer Center, Tampa
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT04981119Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- Miami VA Healthcare System, Miami, FL, Miami
Recruiting
Ages 18 and older · All sexes · Updated Oct 23, 2026 · NCT02984761A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Sylvester Comprehensive Cancer Center, Miami
- Hematology Oncology Associates of the Treasure Coast, Port Saint Lucie
RecruitingPhase 1
Ages 18 and older · Men · Updated Oct 20, 2026 · NCT07103018A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
- Moffitt Cancer Center /ID# 279068, Tampa
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT07409246A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
- Moffitt Cancer Center /ID# 272628, Tampa
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT06892522Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- Boca Raton Clinical Research Associates, Plantation
- H Lee Moffitt Cancer Center and Research Institute, Tampa
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT06162221Galleri® in the Medicare Population.
- USF Morsani Center for Advanced Healthcare, Tampa
RecruitingHealthy volunteers welcome
Ages 50 and older · All sexes · Updated Oct 19, 2026 · NCT05673018INTERogating Cancer for Etiology, Prevention and Therapy Navigation
- Mayo Clinic in Florida, Jacksonville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 16, 2026 · NCT06008392A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Mayo Clinic Pharmacy, Jacksonville
- Mayo Clinic, Jacksonville
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT06989437A Study of ASP3082 in Adults With Advanced Solid Tumors
- University of Florida, Davis Cancer Center, Gainesville
- Florida Cancer Specialists & Research Institute Sarasota, Sarasota
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT05382559A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC
- University of Miami, Miami
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 13, 2026 · NCT07725796A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Mayo Clinic Hospital Jacksonville /ID# 274472, Jacksonville
- Moffitt Cancer Center /ID# 274372, Tampa
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 9, 2026 · NCT07023289From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.